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Abstract Reactive oxygen species (ROS) have been found to
trigger apoptosis in tumor cells. At the same time, telomerase is
found to be associated with malignancy and reduced apoptosis.
However little is known about the linkage between ROS such as
OH and telomerase/telomere. To address the interrelations
between OH and telomerase/telomere in tumor cell killing,
HeLa, 293 and MW451 cells were induced to undergo apoptosis
with OH radicals generated via Fe2+-mediated Fenton reactions
(0.1 mM FeSO4 plus 0.3^0.9 mM H2O2) and telomerase
activity, telomere length were measured during apoptosis. We
found that during OH-induced apoptosis, telomere shortening
took place while no changes in telomerase activity were observed.
Our results suggest that OH-induced telomere shortening is
not through telomerase inhibition but possibly a direct effect
of OH on telomeres themselves indicating that telomere
shortening but not telomerase inhibition is the primary event
during OH-induced apoptosis. Strikingly, we also found that
OH-induced apoptosis in HeLa cells is caspase-3-independent
but is associated with reduction of mitochondrial transmembrane
potential. Our results indicate that OH triggers apoptotic tumor
cell death through a telomere-related, caspase-independent
pathway. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Reactive oxygen species (ROS) generation has been found
to be an important event in apoptotic tumor cell death in-
duced by various anti-cancer agents such as camptothecin,
vinblastine, inostamycin and adrimycin [1]. On the other
hand, ROS scavengers such as N-acetyl-L-cysteine and gluta-
thione (GSH) have been found to inhibit apoptosis induced by
TGFL-1, TNF-K and growth factor deprivation in IL-3-de-
pendent murine pro-B lymphocyte, murine T cell hybridoma,
human ovarian carcinoma and Hit cells [2^4]. Hence explora-
tion of the mechanism underlying ROS-triggered apoptosis in
tumor cells is crucial to our understanding of the chemother-
apeutic e¡ect of anti-cancer drugs.
At the same time, telomerase has become a potential target
for anti-cancer therapeutic application based on the strong
correlation between telomerase activity and malignancy [5].
Furthermore, it was found that inhibition of telomerase either
by oligonucleotides against human telomerase RNA or via
dominant-negative mutants of hTERT (human telomerase re-
verse transcriptase) in human tumor cells leads to progressive
telomere shortening and apoptotic cell death [6,7]. In human
¢broblasts, rate of telomere shortening was increased by mild
hyperoxia and hydrogen peroxide [8,9]. It is thus intriguing to
study the interrelation between ROS action and telomere/
telomerase during apoptosis.
Moreover, in recent years mitochondria have been found to
play a speci¢c role in apoptosis. At least three mitochondrial
events, including loss of mitochondrial transmembrane poten-
tial (v8m), induction of mitochondrial permeability transition
(MPT), and cytosolic translocation of cytochrome c which
participates in the activation of caspase-3, have been found
to be essential components of the apoptotic pathway [10^15].
Moreover, advanced telomere shortening was reported in
blood cells from patients with respiratory chain disorders [16].
To investigate the mechanism during anti-cancer agent-in-
duced tumor cell death, HeLa, 293 and MW451 cells were
induced to undergo apoptosis with hydroxyl radicals (OH)
generated directly via Fe2-mediated Fenton reaction and the
changes in telomerase activity and telomere length during
apoptosis and their relations to mitochondria-related apo-
ptotic pathway were studied. We found that OH caused se-
vere telomere shortening while with no e¡ect on telomerase
activity and induced loss of v8m in the absence of caspase
activation.
Our study provided evidence for the decisive and central
role of ROS in a telomere-related, caspase-independent apo-
ptotic pathway in human tumor cells. To our knowledge this
is the ¢rst report about the linkage between OH and telomere
shortening and telomerase activity during apoptosis.
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2. Materials and methods
2.1. Materials
3,3P-Diethyloxadicarbocyanine (DODCB), pepstatin A, leupeptin,
GSH, rhodamine 123 (Rh 123), 4P,6-diamidino-2-phenylindole
(DAPI), ethidium bromide, 3,3P-dihexyloxacarbocyanine iodide (Di-
OC6(3)), Ac-Asp-Glu-Val-Asp-acid aldehyde (Ac-DEVD-CHO), glu-
taraldehyde, propidium iodide and osmium tetroxide were purchased
from Sigma. 1,4-Dithiothreitol (DTT) was from Promega. Other sub-
stances were from commercial sources and of analytical grade. TU-
NEL (terminal deoxynucleotidyltransferase (TdT)-mediated dUTP
nick end labeling) kit and telomerase assay kit were purchased from
Boehringer Mannheim. All cell culture reagents were purchased from
Gibco.
The (CCCTAA)3 PNA probe was synthesized using the Expedite
8909 Nucleic Acid Synthesis System (PerSeptive Biosystems, Framing-
ham, MA, USA) and was labeled at both the N- and C-termini with
lysine-(5(6)-carboxy£uorescein). The probe was puri¢ed by reverse
phase high performance liquid chromatography at 50‡C and charac-
terized by matrix-assisted laser desorption ionization time-of-£ight
mass spectrometry on a Hewlett Packard G 2025 A mass spectrometer
(Hewlett Packard, San Fernando, CA, USA).
2.2. Cell culture
HeLa and 293 cells were seeded at 1U105 cells per culture £ask in
10 ml of DMEM, MW451 cells were seeded at 1U105 cells per culture
£ask in 10 ml of RPMI 1640. All complete culture media contain 10%
fetal calf serum, 100 Wg/ml of streptomycin, and 100 U/ml of penicil-
lin. Cells were incubated at 37‡C in a humidi¢ed atmosphere contain-
ing 5% CO2. Exponentially growing cells were used for experiments.
Fig. 1. Detection of apoptosis with DAPI in HeLa, MW451 and 293 cells. Cells were treated with 0.1 mM FeSO4/0.6 mM H2O2 for 24 h, then
stained with DAPI and observed under £uorescence microscope. (a, c, e) Control. (b, d, f) OH-treated cells (U725).
Fig. 2. Electron micrograph of HeLa cells undergoing apoptosis after treated by OH for 24 h. (a) Control cells. (b, c) Cells treated with
0.1 mM FeSO4/0.6 mM H2O2 showing chromatin condensation (b) and peripheral distribution (c). Bar, 2 Wm.
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2.3. Induction of apoptosis and experiment treatments
OH radicals were generated through the reaction of 0.1 mM Fe-
SO4 and 0.1, 0.3, 0.6, or 0.9 mM H2O2 and were used for apoptosis
induction for the indicated length of time (from 0 to 24 h).
For telomerase inhibition, cells were preincubated with di¡erent
concentrations of DODCB for 1 h before OH treatment and re-
mained in the medium afterwards. In the experiments using GSH,
cells were pretreated with 1^10 mM GSH for 1 h before apoptosis
induction. For caspase-3 inhibitor treatment, Ac-DEVD-CHO was
added to the medium for 1 h followed by OH treatment.
2.4. Electron microscopic (EM) observation
For EM analysis, cells were harvested and ¢xed in 2% glutaralde-
hyde in 0.05 M phosphate bu¡er, 0.05 M sucrose, pH 7.3 for 2 h at
room temperature. Cells were then post¢xed for 1 h in 1% osmium
tetroxide, dehydrated through a graded series of ethanols, in¢ltrated,
and embedded in Epon. 70 nm sections were collected onto copper
grids, double-stained with oranyl acetate and lead citrate and exam-
ined in a Philips CM 120 transmission electron microscope.
2.5. DAPI staining
Cells were seeded 24 h before FeSO4^H2O2 treatment onto glass
coverslips, precoated with 1 mg/ml of poly-L-lysine (Sigma, Mr
3.7U104) at the density of 3U104 cells/cm2. The cells were rinsed in
D-Hanks’ and ¢xed with methanol. After another rinse, cells were
stained with 1 Wg/ml DAPI (Sigma) in phosphate-bu¡ered saline
(PBS) for 30 min and counted. Apoptotic cells were determined by
evaluating nuclear morphology using a £uorescence microscope (Ni-
kon FLUOPHOT).
2.6. In situ detection of DNA cleavage by the TUNEL procedure
Apoptotic cells were also determined using a TUNEL kit (Boehr-
inger Mannheim) as described by Gavrieli et al. [17]. Brie£y, cells were
plated on glass coverslips and incubated for di¡erent periods of time
in medium with or without FeSO4/H2O2. Cells were then ¢xed in
freshly prepared paraformaldehyde solution (4% in D-Hanks’, pH
7.4) for 30 min at room temperature. After rinsed with D-Hanks’,
cells were permeabilized with 0.1% Triton X-100 in 0.1% sodium cit-
rate bu¡er and incubated for 1 h at 37‡C with TdT and £uorescein
isothiocyanate-dUTP to label the cleaved DNA. After that, coverslips
were mounted in anti-fade mounting solution and observed under a
£uorescence microscope (Nikon FLUOPHOT).
2.7. DNA laddering assay
For the DNA laddering assay, low molecular size DNA was iso-
lated according to the method of Mandal et al. [18]. Brie£y, cells
collected were washed three times with PBS, and resuspended in
1 ml of lysis bu¡er (20 mM Tris^HCl, pH 8.0, 10 mM EDTA, pH
8.0, and 0.5% Triton X-100). After a 90 min incubation on ice, the
lysates were centrifuged at 12 000Ug for 10 min. Low molecular size
DNA in the supernatant was extracted with an equal volume of phe-
nol/chloroform for 1 h at 4‡C. Ammonium acetate (2 M) was added
Fig. 3. Apoptosis in HeLa, MW451, and 293 cells. A: The TUNEL assay. (a) Percentage of TUNEL positive cells as determined after a 24 h
OH treatment. Values are the means þ S.D. of determinations from three separate experiments done in triplicates. Error bars indicate standard
deviations. (b) In situ detection of DNA cleavage in HeLa, MW451 and 293 cells treated with 0.1 mM FeSO4/0.6 mM H2O2. B: DNA ladder-
ing in OH-treated HeLa, MW451 and 293 cells. (a) HeLa cells were treated with 0.1 mM FeSO4 combined with 0.3 mM (lane 3), 0.6 mM
(lane 4), and 0.9 mM (lane 5) H2O2 for 24 h, respectively; lane 1: markers; lane 2: control. (b) MW451 and 293 cells were treated with
0.1 mM FeSO4/0.6 mM H2O2 for 24 h. lane 1: markers; lane 2: MW451 control; lane 3: DNA from OH-treated MW451 cells; lane 4: 293
control; lane 5: DNA from OH-treated 293 cells. C: Quantitative analysis of OH-induced apoptosis in HeLa cells by £ow cytometric analy-
sis. Values are the means of three independent experiments done in triplicates. Error bars indicate standard deviations.
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to the aqueous phase, and DNA was precipitated with two volumes of
ethanol at 320‡C overnight. DNA was then treated with RNase A (1
mg/ml) at 37‡C for 1 h, and total DNA was analyzed using 1.5%
agarose gel electrophoresis. DNA fragments were visualized using
ethidium bromide staining.
2.8. Flow cytometry
Flow cytometry measurements were carried out according to the
methods described by Ishibashi et al. [19]. About 1U106 HeLa cells
were ¢xed in 70% ethanol and then incubated in 1 ml PBS containing
50 Wg/ml propidium iodide and 250 Wg/ml RNase A (Boehringer
Mannheim) at 37‡C for 30 min. The £uorescence intensity was mea-
sured using a Coulter Elite Flow Cytometer. For each sample, 20 000
cells were analyzed using the Coulter Elite workstation 4.0 software
(Coulter Corp.).
2.9. Detection of telomerase activity
Telomerase activity was measured using a PCR-based telomeric
repeat ampli¢cation protocol (TRAP) enzyme-linked immunosorbent
assay (ELISA) kit (Boehringer Mannheim) according to the manufac-
turer’s description with some modi¢cations. In brief, approximately
1U106 cells were lysed in 200 Wl lysis reagent and incubated on ice for
30 min. For conducting TRAP reaction, 2 Wl of cell extract (contain-
ing 2 Wg protein) was added to 25 Wl of reaction mixture and then an
Fig. 4. E¡ect of GSH on OH-induced apoptosis in HeLa cells as detected by the TUNEL procedure, £ow cytometric analysis, and DNA lad-
dering assay. Cells were preincubated with GSH for 1 h before a 24 h OH treatment. A: Percentage of TUNEL positive cells. B: Percentage
of Sub-G1 cells. Values are the means þ S.D. of three independent experiments done in triplicates. Error bars indicate standard deviations.
C: DNA laddering in cells pretreated with GSH followed by 0.1 mM FeSO4/0.6 mM H2O2 treatment. Lane 1: markers; lane 2: control; lane
3: DNA from OH-treated cells ; lanes 4^6: DNA from cells pretreated with 1 mM, 3 mM and 5 mM GSH, respectively.
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appropriate amount of sterile water was added to make a ¢nal volume
of 50 Wl. PCR was performed in a PTC-1001 Programmable Thermal
Controller (MJ Research, Inc.) as follows: primer elongation (30 min,
25‡C), telomerase inactivation (5 min, 94‡C), product ampli¢cation by
repeat of 30 cycles (94‡C for 30 s, 50‡C for 30 s, 72‡C for 90 s).
Hybridization and ELISA reaction were carried out following manu-
facturer’s instruction.
The extract from normal human ¢broblasts served as negative con-
trols. The extract of 293 cells was used as positive controls.
2.10. Measurement of telomere length
Fluorescence in situ hybridization was carried out following the
procedure described by Hultdin et al. [20] and Rufer et al. [21] with
some modi¢cations. Trypsinized HeLa cells were harvested and
washed with ice-cold PBS, centrifuged at 500Ug for 5 min and resus-
pended in 1 ml PBS. Typically, 5U105 cells (each sample was divided
equally into two Eppendorf tubes) were used per tube. After centri-
fugation at 4900Ug for 30 s, the pellets were resuspended in a hy-
bridization mixture containing 70% formamide (Fluka BioChemika,
Buchs, Switzerland), 1% blocking reagent(Boehringer Mannheim
GmbH, Mannheim, Germany) and £uorescein-(CCCTAA)3-£uores-
cein PNA probe synthesized using the Expedite 8909 Nucleic Acid
Synthesis System (PerSeptive Biosystems, Framingham, MA, USA)
in 10 mM Tris pH 7.2. The volume of the hybridization mixture
was adjusted to 100 Wl/105 cells. Samples were heated for DNA de-
naturation for 10 min at 82‡C followed by hybridization in the
dark at room temperature overnight, the cells were centrifuged and
washed twice in PBS at 40‡C. Cells were then resuspended in PBS
containing RNase A at 10 Wg/ml (Boehringer Mannheim) and propi-
dium iodide at 0.1 Wg/ml, vortexing and incubated for 2^4 h at room
temperature and analyzed immediately with a Coulter Elite Flow Cy-
tometer or stored at 4‡C for up to 2 days prior to analysis. For £ow
cytometric analysis, the FL1 channel was used for detection of £uo-
rescein signal and the FL3 channel was for propidium iodide. List
mode data from 1U104 cells in each experiment were collected and
analyzed using Coulter Elite workstation 4.0 software (Coulter
Corp.). The telomere £uorescence signal was de¢ned as the mean
£uorescence signal in cells after substraction of the background £uo-
rescence signal.
2.11. Assay of caspase-3 activity
To measure caspase-3 activity, HeLa cells were harvested and
washed once with ice-cold D-Hanks’ and then resuspended in hypo-
tonic cell lysis bu¡er (25 mM HEPES pH 7.5, 5 mM MgCl2, 5 mM
EDTA, 5 mM DTT, 2 mM PMSF, 10 Wg/ml pepstatin A, 10 Wg/ml
leupeptin) at a concentration of 108 cells/ml, cells were lysed by four
cycles of freezing and thawing, cell lysates were then centrifuged at
16 000Ug for 20 min at 4‡C and the supernatant fraction was col-
lected. Caspase-3 activity was measured using a caspaACE1 Assay
system, Fluorometric kit (Promega), following the manufacturer’s de-
scription. Fluorescence intensity was measured with a £uorescence
spectrophotometer at an excitation wavelength of 360 nm and an
emission wavelength of 460 nm.
2.12. Measurement of mitochondrial transmembrane potential
v8m was measured according to the method of Yang et al. [22]. In
brief, cells were incubated for 30 min in DMEM medium containing
5 WM Rh 123 and were then washed with Locke’s bu¡er (154 mM
NaCl, 5.6 mM KCl, 2.3 mM CaCl2, 1 mM MgCl2, 3.6 mM NaHCO3,
5 mM glucose, 5 mM HEPES, pH 7.2). Cellular £uorescence was
imaged using a confocal laser scanning microscope (MRC-1024,
Bio-Rad) with excitation at 488 nm and emission at 530 nm. The
objective lens was a 100U numerical aperture 1.4 PlanApo lens.
The aperture size of the pinhole was 10V40 nm. Confocal optical
sections were less than 1 mm in thickness. Cells were selected ran-
domly under bright-¢eld optics and then scanned with the laser. Cel-
lular £uorescence levels were quanti¢ed using both Rh 123 and Di-
OC6(3) according to the method of Liu et al. [23] and McDonald et al.
[24] by £ow cytometry (Coulter Elite Flow Cytometer).
2.13. Statistical analysis
Data are expressed as means þ S.D. Signi¢cance was assessed by
two tailed Student’s t-test or one-way analysis of variance (ANOVA).
All data represent at least three independent experiments performed in
triplicates.
3. Results
3.1. Hydroxyl radicals induce apoptosis in
human tumor cells
Human tumor cells including HeLa, MW451, and 293 cells
demonstrated typical morphological and biochemical changes
of apoptotic cells when treated with hydroxyl radicals gener-
ated via the Fe2-mediated Fenton reaction. Cells treated with
OH rounded up and lost their contact with surrounding cells
and ¢nally detached from the surface of culture £asks while
control cells showed normal morphology. DAPI staining
showed disintegration in nuclei of apoptotic HeLa, MW451
and 293 cells (Fig. 1). The apoptotic changes in nuclei includ-
ing condensation and peripheral distribution of chromatin
characteristic of apoptotic cells are further evidenced by EM
observations (Fig. 2).
Moreover, the TUNEL procedure which detects cleavage of
DNA in situ (Fig. 3A) and the assay of DNA laddering (Fig.
3B) which detects internucleosomal DNA degradation showed
the apoptosis-speci¢c DNA fragmentation in OH-induced
human tumor cell death. The £ow cytometric analysis pro-
vided similar results (Fig. 3C).
The results indicate that exogenous OH induces typical
apoptosis in three human tumor cell lines used in this
study.
3.2. OH-induced HeLa cell death was rescued by GSH
When HeLa cells were preincubated with GSH (3 mM,
5 mM), a well-known antioxidant which scavenges free radi-
cals in both in vivo and in vitro systems, for 1 h, the induction
of apoptosis by OH was almost completely eliminated as
shown in Fig. 4. The results thus provided evidence for the
involvement of OH in apoptosis induction.
3.3. OH induces telomere shortening but has no e¡ect on
telomerase activity in human tumor cells
Telomere shortening has been found to account for the
Fig. 5. E¡ect of OH treatment on telomere length and telomerase
activity. A: Telomere length was determined by the method of £uo-
rescence in situ hybridization in OH-treated HeLa cells with or
without GSH pretreatment. B: Telomerase activities in HeLa,
MW451 and 293 cells during apoptosis induction by OH treatment.
Values are means þ S.D. of three separate experiments done in tripli-
cates. Error bars indicate standard deviations. **P6 0.01 compared
with the untreated group and ###P6 0.001 compared with the
0.1 mM FeSO4/0.6 mM H2O2-treated group.
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limitation of the numbers of divisions in normal human ¢bro-
blasts where telomerase activity is not detectable leading to
cellular senescence. Recently, telomere shortening was also
found to take place when immortalized human mammary ep-
ithelial cells were treated with telomerase inhibitors such as
2P-O-MeRNA(2). In this study, we investigated the interrela-
tion between telomeres and hydroxyl radical-induced apopto-
sis and found that telomere length reduced signi¢cantly during
OH-induced apoptosis in HeLa cells. Again, GSH protects
telomere from shortening (Fig. 5A).
Surprisingly, no inhibition in telomerase activity was ob-
served throughout the OH-induced apoptosis in HeLa,
MW451 and 293 cells (Fig. 5B). The results are in accordance
with a recent report regarding the cell killing by paclitaxol in
murine melanoma cells [25], and etoposide, cisplatin, irinote-
can, mitomycin and daunorubicin-mediated apoptosis in leu-
kemic cells [26], as well as sodium butyrate-induced HeLa cell
death [27].
3.4. Inhibition of telomerase activity increases susceptibility of
HeLa cells to OH-induced apoptosis
Although maintenance of telomerase activity does not pro-
tect tumor cells from OH-induced cell killing in our systems,
inhibition of telomerase with DODCB, a commonly used in-
hibitor of telomerase, caused an increased apoptosis at the
same level of OH. As shown in Fig. 6A, 20 WM DODCB
caused a 90% decrease in telomerase activity. When HeLa
cells were preincubated with 20 WM DODCB before treated
with 0.1 mM FeSO4/0.3 mM H2O2, apoptosis was signi¢-
cantly higher than control as detected by the TUNEL assay
and £ow cytometric analysis (Fig. 6B,C). The results suggest
that inhibition of telomerase activity increased markedly the
sensitivity of cells to apoptosis induction by OH. Fig. 6D
showed that more serious DNA laddering was observed
when telomerase was inhibited. The results implicate that
maintenance of telomerase activity is required for prevention
of DNA damage and maintenance of tumor cell viability. It is
Fig. 6. Enhancement of apoptotic cell death in OH-treated HeLa cells by DODCB, a telomerase inhibitor. Cells were preincubated with 20 WM
DODCB for 1 h followed by a 24 h 0.1 mM FeSO4/0.3 mM H2O2 or 0.1 mM FeSO4/0.6 mM H2O2 treatment. A: Telomerase activity in cells
treated with di¡erent concentrations of DODCB. B: Apoptosis detected by the TUNEL procedure. C: Flow cytometric analysis. D: DNA lad-
dering assay. Lane 1, markers; lane 2, control; lane 3, DNA from 0.1 mM FeSO4/0.3 mM H2O2-treated cells; lane 4, DNA from 0.1 mM Fe-
SO4/0.6 mM H2O2-treated cells. Lane 5, DNA laddering in cells pretreated with 20 WM DODCB followed by 0.1 mM FeSO4/0.3 mM H2O2
treatment. Lane 6, DNA from 20 WM DODCB-treated cells. Values are means þ S.D. of three separate experiments done in triplicates. Error
bars indicate standard deviations.
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worth mentioning that DODCB alone does not cause cell
death in HeLa cells and telomere shortening (data not shown).
Our results suggest that telomere length but not telomerase
activity plays a decisive role in apoptotic cell death under our
experimental conditions.
3.5. Caspase activation is not required in OH-induced HeLa
cell death
We further asked if OH-induced apoptosis is associated
with the well-characterized caspase-related apoptotic pathway.
In this study, we studied the e¡ect of Ac-DEVD-CHO, a
speci¢c inhibitor of caspase-3 and caspase-7 to a certain ex-
tent, on OH-induced apoptosis in HeLa cells. It was found
that 0.1 mM Ac-DEVD-CHO showed no e¡ect on DNA lad-
dering (Fig. 7A) and the apoptotic cell death as detected by
£ow cytometric analysis (Fig. 7B). The nature of caspase-
independent apoptosis induced by OH was further veri¢ed
by the assay of caspase-3 activity using a synthetic tetrapep-
tide Ac-DEVD-AMC (Ac-Asp-Glu-Val-Asp-7-amino-4-meth-
yl coumarin) as a speci¢c substrate. It was found that when
0.1 mM FeSO4/0.3 mM H2O2 and 0.1 mM FeSO4/0.6 mM
H2O2 reaction were carried out to generate OH, caspase-3
activity kept unchanged throughout the 24 h incubation (Fig.
7C). The results suggest that OH-induced HeLa cell death is
caspase-independent.
3.6. OH induces reduction of mitochondrial transmembrane
potential (v8m)
Mitochondria are a physiological source of ROS generated
by increased rate of respiration. It was found that ROS gen-
Fig. 7. Independence of caspase-3 in OH-induced apoptotic HeLa cell death as evidenced by the inhibitor (Ac-DEVD-CHO) and study of cas-
pase-3 activity assay. Cells were pretreated with 0.1 mM Ac-DEVD-CHO for 1 h before OH treatment (0.1 mM FeSO4/0.6 mM H2O2) and
then analyzed by DNA laddering assay and £ow cytometry. Caspase-3 activities were determined at di¡erent time points during OH treatment.
A: DNA laddering assay, lane 1: markers; lane 2: control; lane 3: DNA from OH-treated cells ; lane 4: DNA from cells pretreated with
0.1 mM Ac-DEVD-CHO. B: Flow cytometry assay. C: Caspase-3 activity during apoptosis induction. (R) 0.1 mM FeSO4/0.3 mM H2O2 ; (7)
0.1 mM FeSO4/0.6 mM H2O2. Values are means þ S.D. of three separate experiments done in triplicates. Error bars indicate standard devia-
tions.
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eration may cause opening of the MPT pores and loss of
v8m. In this study, we measured the change of v8m after
OH treatment in HeLa cells using Rh 123. We found that
8 h after OH treatment, v8m was only 9.4% of that at zero
time; 24 h after treatment, v8m was almost completely lost.
Strikingly, when cells were pretreated with 5 mM GSH for 1 h
before exposed to OH, about a 71.3% recovery of v8m was
observed (Fig. 8). Similar results were obtained using Di-
OC6(3) (Fig. 9). The results con¢rmed that changes of v8m
were caused by free radicals.
Fig. 10 showed the time course of v8m reduction which
was visualized by laser scan confocal microscopy. This event
is thought to be mediated by the opening of the MPT pore
which is regulated by ROS.
4. Discussion
It was found that ROS mediate apoptosis in various types
of cells and under di¡erent conditions. In addition to the
involvement of ROS in anti-cancer agent-induced apoptotic
tumor cell death, ROS are reported to be involved in excito-
toxic-, staurosporine-, and ceramide-induced neural cell death,
ceramide-induced human leukemic U937 cell death, paraquat-
induced death of endothelial cells, HIV-induced death of T
cells and other apoptotic events [28^39]. However, the mech-
anisms underlying ROS-mediated apoptosis are far from
being clari¢ed.
In this study, we found that GSH can rescue OH-induced
apoptosis in HeLa cells. The results suggest an involvement of
OH functioning as ROS in the induction of apoptotic cell
death. However, in addition to its function as an antioxidant,
GSH also has other e¡ects which may result in changes of
protein folding and functions. To obtain more reliable evi-
dence for the role of OH in apoptosis, genetic overexpression
of catalase should be a more suitable choice. More impor-
Fig. 8. Changes of v8m in OH-treated HeLa cells as measured by
Rh 123 staining. HeLa cells were treated with 0.1 mM FeSO4/
0.6 mM H2O2. A: Changes of v8m during apoptosis as analyzed
by £ow cytometry. B: Reduction of v8m by OH treatment and
the antagonistic e¡ect of GSH. Values are means þ S.D. of three
separate experiments done in triplicates. Error bars indicate stan-
dard deviations.
C
Fig. 9. OH-induced reduction in v8m is concentration-dependent.
HeLa cells were treated with di¡erent concentrations of Fe2/H2O2
for 16 h and measured by DiOC6(3) staining using £ow cytometry.
A: Cells were incubated in the absence or presence of Fe2/H2O2 in
regular medium, labeled with DiOC6(3), and analyzed by £ow cyto-
metry. Representative recordings of six separate measurements are
shown. The reduction in v8m in OH-treated cells is evident from
the decrease in the number of cells with the resting potential as well
as from the appearance of the distinct peak of cells with lower Di-
OC6(3) £uorescence. After a 16 h treatment by 0.1 mM FeSO4/0.9
mM H2O2, v8m was almost completely lost. B: Quantitation of the
reduction v8m in OH-induced apoptosis (means þ S.D., n = 6).
*P6 0.05; **P6 0.01; ***P6 0.001 compared with the untreated
group and #P6 0.05 compared with the 0.1 mM FeSO4/0.6 mM
H2O2-treated group.
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tantly, in our study we found that during OH-induced apo-
ptosis in HeLa cells telomere shortening occurs without inhi-
bition of telomerase activity. The results suggest that ROS-
induced telomere shortening is not through telomerase inhibi-
tion but possibly a direct e¡ect of ROS on telomeres them-
selves. Using a chemical reaction system, Henle et al. [40] and
Oikawa et al. [41] found that OH-mediated DNA oxidations
have preferential cleavage sites which are at the nucleoside 5P
to each of the dG moieties in the sequence RGGG, a sequence
commonly found in telomeres. The results support the possi-
bility that telomere may be a direct target of OH. Further-
more, our ¢nding that maintenance of normal telomerase
activity did not prevent telomere shortening is quite interpret-
able. First, the rate of repairing of telomere by telomerase is
not comparable with that of telomere shortening which is very
dramatic and rapid. Second, it has been documented that
telomerase alone is insu⁄cient for telomere length mainte-
nance, other factors are also required to stabilize telomere
length [42].
Although telomerase inhibition is not required in OH-in-
duced apoptotic tumor cell death, telomerase-inhibited tumor
cells are more susceptible to ROS. As shown in Fig. 6, when
telomerase was inhibited by DODCB and the activity was
only 12% of the original level, a 4-fold increase in percentage
of apoptosis was observed in OH-treated cells as compared
with the control cells in which a normal telomerase activity
was maintained. It is striking that DODCB alone without
OH treatment caused a very low level of apoptosis. This is
in agreement with the data reported by Fu et al. [43] in PC12
cells. The results may have important implications for cancer
chemotherapy since combinations of a telomerase inhibitor
and an anti-cancer drug which induce ROS generation may
be highly e⁄cient in tumor cell killing.
On the other hand, in recent years, caspase-independent
apoptotic cell death has been reported in di¡erent cell sys-
tems. One consistent feature of caspase-independent apoptosis
is the loss or reduction of mitochondrial transmembrane po-
tential (v8m). Our results indicate that OH-induced human
tumor cell death is caspase-independent (Fig. 7) and is also
associated with reduction of v8m (Figs. 8^10). More recently,
apoptosis inducing factor (AIF), a caspase-independent e¡ec-
tor of cell death, was characterized [44]. AIF locates in mito-
chondrial intermembrane space [44,45] and translocates to
nucleus upon apoptosis induction leading to chromatin con-
densation, large scale of DNA fragmentation as well as v8m
reduction [44]. Whether or not ROS a¡ects AIF translocation
is unclear at the present time. However, since MPT pore is
sensitive to ROS, it is likely that ROS may stimulate AIF
translocation. The interaction between ROS and AIF should
be further scrutinized.
In summary, our study provides evidence that telomere
shortening but not telomerase inhibition is the primary event
during OH-induced apoptosis in human tumor cells. We also
found that ROS play a decisive role in human cell death by
targeting directly at telomere and also mitochondria in some-
way a¡ecting mitochondrial transmembrane potential and
downstream events. Our study may have some implications
for the strategy of development of cocktails of chemothera-
peutic agents. For example, combinations of telomerase inhib-
itor and anti-cancer agent that generates ROS and shorten
telomeres would be highly e¡ective for cancer treatment.
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